Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo.
about
Review of the pharmacokinetics, pharmacogenetics, and drug interaction potential of antidepressants: focus on venlafaxine.Metabolic drug interactions with new psychotropic agents.Tacrine is not an ideal probe drug for measuring CYP1A2 activity in vivoQuantitative Prediction of Drug Interactions Caused by CYP1A2 Inhibitors and Inducers.Interaction study between fluvoxamine and quazepam.In-vitro stability and metabolism of a tacrine-silibinin codrug.
P2860
Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo.
@ast
Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo.
@en
Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo.
@nl
type
label
Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo.
@ast
Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo.
@en
Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo.
@nl
prefLabel
Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo.
@ast
Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo.
@en
Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo.
@nl
P2093
P356
P1476
Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo.
@en
P2093
P2888
P304
P356
10.1007/S002280050643
P50
P577
1999-07-01T00:00:00Z
P6179
1005414529